Latest glioblastoma multiforme Stories
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
Industry and Academic Leader Co-Founded Several Successful Biotechnology Companies, Including Alnylam, Cubist and Alkermes SAN DIEGO, Feb.
- Updated Phase I/II clinical trial data on the maximum tolerated dose for VAL-083 in the treatment of glioblastoma multiforme (GBM) to be presented - VANCOUVER, British Columbia
NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.
BETHESDA, Md., Feb. 19, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
COVINGTON, Ky., Feb. 16, 2015 /PRNewswire/ -- Bexion Pharmaceuticals LLC announced today that the U.S.
RnRMarketResearch.com adds “Malignant Glioma – Pipeline Review, H1 2015” report to its store.
- Management to host live investor conference call and webcast on February 17, 2015 at 1:30 PM PST - VANCOUVER, British Columbia and MENLO PARK, Calif., Feb.
CALGARY, Feb. 9, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
- The abrogation of a law by a higher authority; annulment.
- In music, during the eighteenth century, a song or an instrumental piece similar to the serenade, intended for performance in the open air.